The round also saw participation from Huddle Ventures, Lotus Herbal Group, Steerx, and Tremis Capital.
Founded by Amar Sneh and Deepak Kumar in 2023, Oncare is aiming to build a pan-India chain of single-speciality cancer centres. Currently, it has four operational centres across Delhi-NCR. Both the founders previously worked at Pristyn Care, which is a platform helping patients book surgeries via partner hospitals and doctors.
“We’ll use this round to expand into Bangalore and open a few tertiary-city centres over the next year and largely across the eastern belt like UP, Bihar, and West Bengal, where the demand-supply gap is massive, and many patients currently travel to Delhi for treatment,” said Deepak Kumar, cofounder of Oncare.
Oncare positions itself as a more affordable alternative, claiming it can price chemotherapy around 40% lower than corporate hospitals, at about Rs 24,000-25,000 per session versus Rs 40,000, and surgeries typically 30-40% cheaper.
“Affordability and transparency remain the two biggest pain points in cancer care, with treatment costs often running upwards of Rs 10 lakh at large corporate hospitals and patients struggling to understand what the next steps will look like,” Kumar added.
According to the startup, since its inception, Oncare has interacted with around 30,000 patients, with about 3,000 consultations conducted by its oncologists and roughly 1,000 patients undergoing treatment, translating into over 4,000 procedures.
ET has previously reported multiple recent fundraises in the speciality-care delivery space. On January 6, 2026, Even Healthcare raised $20 million in a round led by Lachy Groom and Alpha Wave, with participation from Sharrp Ventures. On November 6, 2025, Policybazaar Group’s PB Healthcare raised $218 million in its maiden institutional funding round.
On January 27, 2026, Nivaan Care secured $7 million in a Series A round led by Sorin Investments, with participation from W Health Ventures, Endiya, and Rebright.
